Development of Brimonidine-Loaded Ethosomes for Glaucoma: Investigation of Intraocular Pressure-Lowering Potential In Vivo

<b>Background/Objectives</b>: Brimonidine tartrate (BRT), a selective α2-adrenergic receptor agonist, is commonly used in the treatment of glaucoma. However, conventional eye drop formulations suffer from poor ocular bioavailability and rapid elimination. This study aimed to develop and evaluate BRT...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Samet Özdemir, Ali Asram Sağıroğlu, Eslim Şen, Büşra Gelmez Yıldız, Laman Karimli, Meltem Ezgi Durgun Kılıç, Ali Riza Cenk Celebi, Yıldız Özsoy
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2026-02-01
Serie:	Pharmaceutics
Soggetti:	brimonidine tartrate ethosomes HET-CAM intraocular pressure glaucoma ophthalmic drug delivery
Accesso online:	https://www.mdpi.com/1999-4923/18/2/210
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!